bioRxiv Science⌕ Search
Home/Archive/bioRxiv

bioRxiv · 10.64898/2026.04.17.719144

Large-scale analysis of ligand binding mode similarities in the PDB using interaction fingerprints

Kunnakkattu, I. R.·Choudhary, P.·Midlik, A.·Fleming, J. R.·Balasubramaniyan, B.·Sasidharan Nair, S.·Velankar, S.
View original source ↗Export metadata ↓

Abstract

Three-dimensional structures of protein-ligand complexes are essential for insights into the molecular principles that govern ligand recognition and binding. With more than 180,000 ligand-bound entries in the Protein Data Bank (PDB), representing over two million individual complexes, the volume of available structural data offers unprecedented opportunities for large-scale analysis of interaction patterns. Analysis of interaction patterns across the PDB archive can help discover similarities and differences in the binding modes of ligands, assisting in drug discovery. However, large-scale analysis of up-to-date information remains a significant challenge due to the rapid growth of data. Here, we introduce the Extended Connectivity Interaction Fingerprint (ECIFP), an interaction-based fingerprint that simplifies 3D protein-ligand contact information into a fingerprint, while retaining key molecular and chemical features of the interacting fragments. The simpler fingerprint representation of the interaction data makes comparison of millions of protein-ligand complexes tractable. Benchmarking shows that ECIFP outperforms ligand-only Extended Connectivity Fingerprints in identifying similar binding sites across identical protein sequences occupied by chemically diverse ligands. Our analysis showed that similarities calculated using ECIFP can be used to compare macromolecular complexes with similar or different ligands. In this study, we demonstrate two large-scale applications of ECIFP: (1) identification of distinct binding modes for over 9,000 ligands across the entire PDB, and (2) detection of binding-mode similarities among structurally diverse ligands within the same binding site across 48,870 binding sites from over 21,000 proteins.

Explore related subjects

bioinformaticsPreprint

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Kunnakkattu, I. R., Choudhary, P., Midlik, A., Fleming, J. R., Balasubramaniyan, B., Sasidharan Nair, S., Velankar, S.. 2026-04-21. Large-scale analysis of ligand binding mode similarities in the PDB using interaction fingerprints. https://doi.org/10.64898/2026.04.17.719144

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

bioRxiv2026

Senescence-associated KRAS upregulation in peripheral T cells links to premature coronary artery disease

Aims: Premature coronary artery disease (PCAD) lacks specific molecular drivers, and the role of immunosenescence is unclear. We investigated whether aging-related gene dysregulation in T cells contributes to PCAD. Methods: We combined bulk transcriptomics of PBMCs from 12 PCAD patients and 21 controls, single-cell RNA sequencing of PBMCs and human atherosclerotic plaques, weighted gene co-expression network analysis, gene perturbation network analysis, and molecular docking. Results: KRAS was identified as a hub gene intersecting PCAD-associated genes and aging-related genes. Single-cell analysis showed KRAS upregulation predominantly in effector CD8+ T cells, which exhibited the highest senescence scores that were further elevated in disease. Network perturbation of KRAS strongly impacted the cell killing pathway. KRAS-high effector CD8+ T cells were detected in coronary and carotid plaques, displaying enhanced cytotoxicity, exhaustion, and senescence features. Additionally, a candidate small molecule was computationally predicted to bind inactive KRAS. Conclusions: Elevated KRAS expression in senescent, cytotoxic CD8+ T cells is associated with PCAD, bridging immunosenescence and premature atherosclerosis. This finding provides a novel biomarker candidate and potential therapeutic entry point, awaiting further functional validation.

bioinformatics↗
bioRxiv2026

Targeted finetuning enables co-folding models to learn ligand-induced protein conformational states

Advances in protein structure prediction have enabled all-atom protein-ligand co-folding models that predict bound conformations directly from sequence and small-molecule structure. However, these models often fail to generalize to novel binding sites or alternative protein conformational states, limiting their utility for chemical biology and drug discovery. Here we show this limitation reflects training data bias rather than architectural constraints and can be overcome through targeted finetuning. Using ten previously unseen X-ray structures of Werner (WRN) helicase from a drug discovery program, we finetune Boltz-1 to learn both an allosteric binding site and a large conformational change locking the enzyme in an inactive state, while preserving accuracy on the ATP-bound state. The finetuned model generalizes to different chemical series and transfers the conformational logic across RecQ-family helicases in a binding-site sequence-dependent manner. This approach provides a blueprint for adapting foundation models as new structural and mechanistic data emerge, enabling co-folding networks to capture ligand-induced conformational switches and binding poses absent from their training data but central to biological regulation and therapeutic intervention.

bioinformatics↗
bioRxiv2026

Benchmarking single-cell foundation models for aging biology

Single cell foundation models (scFMs) provide representations of cellular states, but their utility across biological questions in aging research remains unclear. We established a benchmark of cellular representations for aging research, evaluating ten general-purpose scFMs, three aging-specific models and conventional methods across five biological questions using more than 2.5 million single cell transcriptomes. Using frozen pretrained representations, Geneformer performed best among scFMs for chronological age prediction and age pseudotime concordance, although 2,000 highly variable genes achieved higher mean performance. Several scFMs captured positive molecular age shifts across three disease contexts, consistent with reported aging-associated changes. SCimilarity performed well for rare cellular state identification across out-of-distribution datasets, exceeding aging specific models and conventional baselines. At the gene level, scGPT showed the highest recovery of reference TF target interactions, including aging-related regulatory hubs. Overall, scFMs supported diverse aging analyses, but performance depended on the biological question, highlighting their utility for rare cellular state identification and regulatory analysis.

bioinformatics↗